Prostaglandin E1 Improves Endothelial Function in Critical Limb Ischemia

Prostaglandin E1 (PGE1) may relieve rest pain and heal ulcers in critical limb ischemia, but its mechanism of action is still incompletely understood. To investigate the effects of PGE1 treatment on endothelial function evaluated as brachial artery flow-mediated vasodilation (FMV) and on soluble adhesion molecule plasma levels (vascular adhesion molecule-1 [sVCAM-1] and intercellular adhesion molecule-1 [sICAM-1]), 12 patients with critical limb ischemia were treated with daily PGE1 IV infusion (alprostadil 60 &mgr;g) for 2 weeks. FMV and plasma sICAM-1 and sVCAM-1 concentrations were determined at baseline, after the first infusion, and after 1 and 2 weeks. Compared with 30 healthy control subjects, patients had higher baseline sVCAM-1 (2.402 ± 296 ng/ml vs 972 ± 117 ng/ml) and sICAM-1 levels (464 ± 51 ng/ml vs 206 ± 37 ng/ml, both p < 0.05) and lower FMV (1.0 ± 1.1% vs 5.6 ± 1.6%, p < 0.05). sICAM-1 concentration progressively decreased with treatment (from 464 ± 51 ng/ml to 326 ± 56 ng/ml, 288 ± 42 ng/ml, and 279 ± 44 ng/ml after the first dose and, respectively, after 1 and 2 weeks; all p < 0.05). sVCAM-1 showed a reduction after 2 weeks (from 2.402 ± 296 ng/ml to 1.916 ± 176 ng/ml; p < 0.05). FMV improved after 1 and 2 weeks (from 1.0 ± 1.1% to 3.1 ± 0.6% and 5.2 ± 2.1%, both p < 0.05). In conclusion, treatment with PGE1 determines a significant improvement in endothelial function in patients with critical limb ischemia.

[1]  E. Benjamin,et al.  Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. , 2002, Journal of the American College of Cardiology.

[2]  R. de Caterina,et al.  Intravenous prostaglandin E1 reduces soluble vascular cell adhesion molecule-1 in peripheral arterial obstructive disease. , 2001, American heart journal.

[3]  S. Blankenberg,et al.  Circulating Cell Adhesion Molecules and Death in Patients With Coronary Artery Disease , 2001, Circulation.

[4]  T. de Cristofaro,et al.  High Levels of Adhesion Molecules Are Associated with Impaired Endothelium-dependent Vasodilation in Patients with Peripheral Arterial Disease , 2001, Thrombosis and Haemostasis.

[5]  E. Mannarino,et al.  Impaired flow-mediated vasoactivity during post-prandial phase in young healthy men. , 2000, Atherosclerosis.

[6]  B. Palumbo,et al.  Prostaglandin E1-therapy reduces circulating adhesion molecules (ICAM-1, E-selectin, VCAM-1) in peripheral vascular disease. , 2000, VASA. Zeitschrift fur Gefasskrankheiten.

[7]  K. Kostner,et al.  Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. , 2000, The American journal of cardiology.

[8]  M. Mas,et al.  Repeated PGE1 treatment enhances nitric oxide and erection responses to nerve stimulation in the rat penis by upregulating constitutive NOS isoforms. , 1999, The Journal of urology.

[9]  G. Sobal,et al.  Effects of PGI2 and analogues (taprostene, iloprost) on oxidation of native and glycated LDL. , 1999, Life sciences.

[10]  M. Corretti,et al.  Endothelial reactivity and cardiac risk factors in older patients with peripheral arterial disease. , 1999, The American journal of cardiology.

[11]  Prostanoids for Chronic Critical Leg Ischemia , 1999, Annals of Internal Medicine.

[12]  E. Boerwinkle,et al.  Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. , 1997, Circulation.

[13]  H. Shimada,et al.  Prostaglandin E1 protects against ischemia-reperfusion injury of the liver by inhibition of neutrophil adherence to endothelial cells. , 1997, Transplantation.

[14]  R. de Caterina,et al.  Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[15]  M. Gimbrone,et al.  Biomechanical activation: an emerging paradigm in endothelial adhesion biology. , 1997, The Journal of clinical investigation.

[16]  C. Bode,et al.  Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[17]  D. Glogar,et al.  Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. , 1997, Atherosclerosis.

[18]  R. Snyderman,et al.  Mechanisms of inflammation and leukocyte activation. , 1997, The Medical clinics of North America.

[19]  H. Sinzinger,et al.  Prostaglandin E1 decreases human arterial accumulation of radiolabeled apo B-containing lipoproteins in vivo , 1997, European Journal of Clinical Pharmacology.

[20]  U. Ikeda,et al.  Nitric oxide attenuates adhesion molecule expression in human endothelial cells. , 1996, Cytokine.

[21]  D. Tsikas,et al.  L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study. , 1996, Circulation.

[22]  J P Cooke,et al.  Exposure to shear stress alters endothelial adhesiveness. Role of nitric oxide. , 1995, Circulation.

[23]  A. Yeung,et al.  Close relation of endothelial function in the human coronary and peripheral circulations. , 1995, Journal of the American College of Cardiology.

[24]  J. Ricotta,et al.  Vascular reactivity in patients with peripheral vascular disease. , 1995, The American journal of cardiology.

[25]  W E Haefeli,et al.  Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. , 1995, Circulation.

[26]  J. K. Lloyd,et al.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis , 1992, The Lancet.

[27]  A. Gearing,et al.  Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. , 1992, Biochemical and biophysical research communications.

[28]  H. Drexler,et al.  Flow-dependent coronary artery dilatation in humans. , 1989, Circulation.

[29]  R. Türker,et al.  Iloprost maintains acetylcholine relaxations of isolated rabbit aortic strips submitted to hypoxia. , 1988, Pharmacology.

[30]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.